Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study
- DOI
- 10.1016/s2213-2600(26)00096-2
- Published
- 2026-08
- Container
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2213-2600-26-00096-2,
title = {Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study},
author = {Jennifer Logan and Kirsty Martin and Lynsey Gillespie and Alex McConnachie and Wai-Ting Nicola Lee and Hassan Burhan and Thomas Brown and Shoaib Faruqi and David J Jackson and Ramesh Kurukulaaratchy and Adel H Mansur and Dinesh Saralaya and Stephen J Fowler and Pujan Patel and James Brown and James Lordan and Salman Siddiqui and Steven James Smith and Peer Ameen Shah and Koirobi Haldar and Spyridon Megremis and Sophie A Harrison and Rhys Brown and Charlotte Nelson and Vijay Mistry and Vanessa Brown and James D Chalmers and Ratko Djukanovic and Ian D Pavord and Liam G Heaney and Christopher E Brightling and Rekha Chaudhuri},
year = {2026},
journal = {The Lancet Respiratory Medicine},
doi = {10.1016/s2213-2600(26)00096-2},
url = {https://doi.org/10.1016/s2213-2600(26)00096-2}
}RIS
TY - JOUR TI - Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study AU - Jennifer Logan AU - Kirsty Martin AU - Lynsey Gillespie AU - Alex McConnachie AU - Wai-Ting Nicola Lee AU - Hassan Burhan AU - Thomas Brown AU - Shoaib Faruqi AU - David J Jackson AU - Ramesh Kurukulaaratchy AU - Adel H Mansur AU - Dinesh Saralaya AU - Stephen J Fowler AU - Pujan Patel AU - James Brown AU - James Lordan AU - Salman Siddiqui AU - Steven James Smith AU - Peer Ameen Shah AU - Koirobi Haldar AU - Spyridon Megremis AU - Sophie A Harrison AU - Rhys Brown AU - Charlotte Nelson AU - Vijay Mistry AU - Vanessa Brown AU - James D Chalmers AU - Ratko Djukanovic AU - Ian D Pavord AU - Liam G Heaney AU - Christopher E Brightling AU - Rekha Chaudhuri PY - 2026 JO - The Lancet Respiratory Medicine DO - 10.1016/s2213-2600(26)00096-2 UR - https://doi.org/10.1016/s2213-2600(26)00096-2 ER -
APA
Logan, J., Martin, K., Gillespie, L., McConnachie, A., Lee, W. N., Burhan, H., Brown, T., Faruqi, S., Jackson, D. J., Kurukulaaratchy, R., Mansur, A. H., Saralaya, D., Fowler, S. J., Patel, P., Brown, J., Lordan, J., Siddiqui, S., Smith, S. J., Shah, P. A., Haldar, K., Megremis, S., Harrison, S. A., Brown, R., Nelson, C., Mistry, V., Brown, V., Chalmers, J. D., Djukanovic, R., Pavord, I. D., Heaney, L. G., Brightling, C. E., & Chaudhuri, R. (2026). Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(26)00096-2
Source records
- crossref · retrieved 2026-09-27T05:04:13.319Z